FDA halts study of asthma drug

WASHINGTON, Jan. 24 (UPI) -- The Food and Drug Administration halted a safety study of an approved asthma drug Thursday when data indicated it could cause death in some patients. The drug, Serevent Inhalation Aerosol, was first approved in the United States in 1994 for treating asthma and later for treating chronic obstructive pulmonary disease.